MARKET

EMMA

EMMA

Emmaus Life Scie
OTCMQB
0.011
NaN%
Opening 09:30 06/15 EDT
OPEN
--
PREV CLOSE
0.011
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.018
52 WEEK LOW
0.0086
MARKET CAP
772.07K
P/E (TTM)
-0.0859
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at EMMA last week (0608-0612)?
Weekly Report · 4h ago
Weekly Report: what happened at EMMA last week (0601-0605)?
Weekly Report · 06/08 09:37
Weekly Report: what happened at EMMA last week (0525-0529)?
Weekly Report · 06/01 09:39
Weekly Report: what happened at EMMA last week (0518-0522)?
Weekly Report · 05/25 09:40
Weekly Report: what happened at EMMA last week (0511-0515)?
Weekly Report · 05/18 09:40
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S. 
Reuters · 05/15 20:00
EMMAUS LIFE SCIENCES Q1 OPERATING EXPENSES USD 2.637 MILLION
Reuters · 05/15 19:51
EMMAUS LIFE SCIENCES REPORTS QUARTERLY FINANCIAL RESULTS
Reuters · 05/15 19:51
More
About EMMA
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery, development, marketing and sale of treatments and therapies, primarily for rare and orphan diseases. Its lead product, Endari (prescription grade L-glutamine oral powder) helps to reduce the acute complications of sickle cell disease (SCD) in adult and pediatric patients five years of age and older. Its product pipeline includes ELS001/ELS007, ELS004, ELS005, ELS003, and ELS002. The Company, through Kainos Medicine, Inc. (Kainos), has a license in the territory encompassing the United States, the United Kingdom, and the European Union to patent rights, know-how, and other intellectual property relating to Kainos’s IRAK4 inhibitor, referred to as KM10544, for the treatment of cancers, including leukemia, lymphoma, and solid tumor cancers. The Company has also developed chondrocyte and osteoblast cell sheets using human mesenchymal stem cells.

Webull offers Emmaus Life Sciences Inc stock information, including OTCMQB: EMMA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EMMA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EMMA stock methods without spending real money on the virtual paper trading platform.